Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -1166.77% is 14% above its 5-year average of -1358.20%, near the high end of its 5-year range (-11279.88%–85.80%).
9.07% below its 12-month average of -1069.79%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -956.77%.
OPERATING MARGIN
-1166.77%
OPERATING MARGIN AVG TTM
-1069.79%
OPERATING MARGIN AVG 3Y
-1261.69%
OPERATING MARGIN AVG 5Y
-1358.20%
OPERATING MARGIN AVG 10Y
-1223.20%
OPERATING MARGIN AVG 15Y
-973.23%
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-9.07%
CURRENT VS 3Y AVG
+7.52%
CURRENT VS 5Y AVG
+14.09%
CURRENT VS 10Y AVG
+4.61%
CURRENT VS 15Y AVG
-19.89%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 809 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
uniQure N.V.
Market Cap
$1.53B
Operating Margin
-1166.77%
TTM Avg
-1069.79%
3Y Avg
-1261.69%
5Y Avg
-1358.20%
Market Cap
$1.53B
Operating Margin
-11.16%
TTM Avg
-144.24%
3Y Avg
-609.23%
5Y Avg
-406.15%
Market Cap
$1.53B
Operating Margin
31.49%
TTM Avg
29.35%
3Y Avg
-34.88%
5Y Avg
-5.38%
Market Cap
$1.54B
Operating Margin
-158.45%
TTM Avg
-796.44%
3Y Avg
-398.22%
5Y Avg
-1047.05%
Market Cap
$1.54B
Operating Margin
36.66%
TTM Avg
42.52%
3Y Avg
46.05%
5Y Avg
62.54%
Market Cap
$1.49B
Operating Margin
0.09%
TTM Avg
-3.29%
3Y Avg
-12.30%
5Y Avg
-11595.24%
Market Cap
$1.49B
Operating Margin
13.07%
TTM Avg
10.79%
3Y Avg
8.54%
5Y Avg
8.59%
Market Cap
$1.46B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| uniQure N.V. (QURE) | $1.53B | -1166.77% | -1069.79% | -1261.69% | -1358.20% |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.53B | -11.16% | -144.24% | -609.23% | -406.15% |
| Nutex Health, Inc. (NUTX)vs › | $1.53B | 31.49% | 29.35% | -34.88% | -5.38% |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | -158.45% | -796.44% | -398.22% | -1047.05% |
| Innoviva, Inc. (INVA)vs › | $1.54B | 36.66% | 42.52% | 46.05% | 62.54% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.49B | 0.09% | -3.29% | -12.30% | -11595.24% |
| Phibro Animal Health Corporation (PAHC)vs › | $1.49B | 13.07% | 10.79% | 8.54% | 8.59% |
| GH Research PLC (GHRS)vs › | $1.46B | 0.00% | 0.00% | 0.00% | 0.00% |
| Rapport Therapeutics, Inc. Common Stock (RAPP)vs › | $1.46B | 0.00% | 0.00% | 0.00% | 0.00% |
| Omnicell, Inc. (OMCL)vs › | $1.59B | 4.73% | 0.51% | -0.21% | 1.84% |
Gross Margin
89.5%
Operating Margin
-1166.8%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -956.77% |
| 2026-03-31 | -1242.81% |
| 2025-12-31 | -936.80% |
| 2025-09-30 | -1378.95% |
| 2025-06-30 | -833.62% |
| 2025-03-31 | -2509.96% |
| 2024-12-31 | -877.76% |
| 2024-09-30 | -1758.99% |
| 2024-06-30 | -395.56% |
| 2024-03-31 | -639.10% |
| 2023-12-31 | -923.13% |
| 2023-09-30 | -5819.26% |
| 2023-06-30 | -2686.79% |
| 2023-03-31 | -1392.90% |
| 2022-12-31 | 25.79% |
| 2022-09-30 | -4107.52% |
| 2022-06-30 | -11279.88% |
| 2022-03-31 | -3017.86% |
| 2021-12-31 | 3.58% |
| 2021-09-30 | -2262.44% |
| 2021-06-30 | 85.80% |
| 2021-03-31 | -9792.51% |
| 2020-12-31 | -24.25% |
| 2020-09-30 | -2486.86% |
| 2020-06-30 | -2489.12% |
| 2020-03-31 | -33137.50% |
| 2019-12-31 | -1256.34% |
| 2019-09-30 | -2994.84% |
| 2019-06-30 | -1185.57% |
| 2019-03-31 | -2421.13% |
| 2018-12-31 | -1505.35% |
| 2018-09-30 | -737.74% |
| 2018-06-30 | -695.18% |
| 2018-03-31 | -563.51% |
| 2017-12-31 | -876.35% |
| 2017-09-30 | -410.40% |
| 2017-06-30 | -398.79% |
| 2017-03-31 | -593.65% |
| 2016-12-31 | -128.30% |
| 2016-09-30 | -206.48% |
| 2016-06-30 | -478.86% |
| 2016-03-31 | -552.61% |
| 2015-12-31 | -369.16% |
| 2015-09-30 | -858.79% |
| 2015-06-30 | -1152.20% |
| 2015-03-31 | -786.54% |
| 2014-12-31 | -638.65% |
| 2014-09-30 | -788.51% |
| 2014-06-30 | -842.51% |
| 2014-03-31 | -649.32% |
| 2013-12-31 | -755.81% |
| 2013-09-30 | -416.55% |
| 2013-06-30 | -673.09% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
